B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)
Authors
Keywords
BAFF, BLyS, Lupus, SLE, Belimumab
Journal
AUTOIMMUNITY REVIEWS
Volume 20, Issue 2, Pages 102736
Publisher
Elsevier BV
Online
2020-12-16
DOI
10.1016/j.autrev.2020.102736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients
- (2020) Yongjian Chen et al. AUTOIMMUNITY
- Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus
- (2020) Mariele Gatto et al. Arthritis & Rheumatology
- Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
- (2020) Fabio Basta et al. Rheumatology and Therapy
- Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol
- (2019) Y K Onno Teng et al. BMJ Open
- High BAFF expression associated with active disease in systemic lupus erythematosus and relationship with rs9514828C>T polymorphism in TNFSF13B gene
- (2019) M. Marín-Rosales et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Antimalarial agents diminish while methotrexate, azathioprine and mycophenolic acid increase BAFF levels in systemic lupus erythematosus
- (2019) Borja Hernández-Breijo et al. AUTOIMMUNITY REVIEWS
- Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis
- (2019) Justa Friebus-Kardash et al. BMC Nephrology
- Lupus serum IgG induces microglia activation through Fc fragment dependent way and modulated by B-cell activating factor
- (2019) Chunshu Yang et al. Journal of Translational Medicine
- Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial
- (2019) Alexis Jones et al. BMJ Open
- B-cell activating factor and related genetic variants in lupus related atherosclerosis
- (2018) Evangelos Theodorou et al. JOURNAL OF AUTOIMMUNITY
- Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus – distinct roles of BAFF and APRIL
- (2018) I Parodis et al. LUPUS
- B-cell activity markers are associated with different disease activity domains in primary Sjögren’s syndrome
- (2018) Katherine James et al. RHEUMATOLOGY
- Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
- (2018) Domenico Paolo Emanuele Margiotta et al. BMC Nephrology
- Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
- (2018) Joan T. Merrill et al. Arthritis & Rheumatology
- Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
- (2018) Joan T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus
- (2018) F B Vincent et al. LUPUS
- High expression of B lymphocyte stimulator in lesional keratinocytes of patients with cutaneous lupus erythematosus
- (2017) Joerg Wenzel et al. EXPERIMENTAL DERMATOLOGY
- BAFF Induces Tertiary Lymphoid Structures and Positions T Cells within the Glomeruli during Lupus Nephritis
- (2017) SunAh Kang et al. JOURNAL OF IMMUNOLOGY
- Profile of BAFF and its receptors’ expression in lupus nephritis is associated with pathological classes
- (2017) J P Suso et al. LUPUS
- Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men
- (2017) A Schwarting et al. LUPUS
- Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus
- (2017) Justa Friebus-Kardash et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Microglia-mediated BAFF–BAFFR ligation promotes neuronal survival in brain ischemia injury
- (2017) Kai Li et al. NEUROSCIENCE
- Overexpression of the Cytokine BAFF and Autoimmunity Risk
- (2017) Maristella Steri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Up-regulated BAFF and BAFF receptor expression in patients with intractable temporal lobe epilepsy and a pilocarpine-induced epilepsy rat model
- (2017) Limin Ma et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
- (2017) William Stohl et al. Arthritis & Rheumatology
- Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis
- (2016) Francesco Ciccia et al. ANNALS OF THE RHEUMATIC DISEASES
- Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis
- (2016) S. Phatak et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Molecular structure, distribution, and immunology function of TNFSF13B (BAFF) in Nile tilapia ( Oreochromis niloticus )
- (2016) Hongzhen Liu et al. FISH & SHELLFISH IMMUNOLOGY
- Characterization of LampreyBAFF-like Gene: Evolutionary Implications
- (2016) Sabyasachi Das et al. JOURNAL OF IMMUNOLOGY
- The BAFFling effects of rituximab in lupus: danger ahead?
- (2016) Michael R. Ehrenstein et al. Nature Reviews Rheumatology
- Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren’s Syndrome
- (2016) Sang Jin Lee et al. Journal of Immunology Research
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) D A Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- The role of BAFF in the progression of rheumatoid arthritis
- (2015) Fang Wei et al. CYTOKINE
- The Expression of BAFF Is Controlled by IRF Transcription Factors
- (2015) Maria Sjöstrand et al. JOURNAL OF IMMUNOLOGY
- Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus
- (2015) D C Salazar-Camarena et al. LUPUS
- Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab
- (2015) D A Roth et al. LUPUS
- Detection of The TNFSF Members BAFF, APRIL, TWEAK and Their Receptors in Normal Kidney and Renal Cell Carcinomas
- (2015) Vassiliki Pelekanou et al. Analytical Cellular Pathology
- Belimumab may not prevent lupus nephritis in serologically active patients with ongoing non-renal disease activity
- (2014) C Sjöwall et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies
- (2014) Olga Kryštůfková et al. ARTHRITIS RESEARCH & THERAPY
- Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials
- (2013) Michelle A. Petri et al. ARTHRITIS AND RHEUMATISM
- BAFF Expression Correlates with Idiopathic Inflammatory Myopathy Disease Activity Measures and Autoantibodies
- (2013) C. M. LOPEZ De PADILLA et al. JOURNAL OF RHEUMATOLOGY
- Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus
- (2013) FB Vincent et al. LUPUS
- Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort
- (2013) E. M. McCarthy et al. RHEUMATOLOGY
- B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
- (2013) Antoine François et al. ARTHRITIS RESEARCH & THERAPY
- Adipose Tissue-Derived Mesenchymal Cells Support Skin Reepithelialization through Secretion of KGF-1 and PDGF-BB: Comparison with Dermal Fibroblasts
- (2012) Vassilia-Ismini Alexaki et al. CELL TRANSPLANTATION
- First BAFF gene cloned from an aquatic mammal
- (2012) Fengtao You et al. GENE
- Molecular cloning, expression, bioinformatics analysis and bioactivity characterization of TNF13B (BAFF) gene in bat (Vespertilio superans Thomas)
- (2012) Fengtao You et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The complexity of the BAFF TNF-family members: Implications for autoimmunity
- (2012) Ayan Lahiri et al. JOURNAL OF AUTOIMMUNITY
- APRIL Binding to BCMA Activates a JNK2-FOXO3-GADD45 Pathway and Induces a G2/M Cell Growth Arrest in Liver Cells
- (2012) G. Notas et al. JOURNAL OF IMMUNOLOGY
- Stromal Endothelial Cells Establish a Bidirectional Crosstalk with Chronic Lymphocytic Leukemia Cells through the TNF-Related Factors BAFF, APRIL, and CD40L
- (2012) M. Cols et al. JOURNAL OF IMMUNOLOGY
- Induction of BAFF expression by IFN- via JAK/STAT signaling pathways in human intestinal epithelial cells
- (2012) S.-J. Woo et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The expression of BAFF in the muscles of patients with dermatomyositis
- (2012) Ahmi Baek et al. JOURNAL OF NEUROIMMUNOLOGY
- BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands
- (2012) L. Quartuccio et al. RHEUMATOLOGY
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: Relation to clinical manifestations and disease activity
- (2011) Tamer A. Gheita et al. JOINT BONE SPINE
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- B Cell-Activating Factor Controls the Production of Adipokines and Induces Insulin Resistance
- (2011) Maho Hamada et al. Obesity
- APRIL and BAFF Proteins Increase Proliferation of Human Adipose-Derived Stem Cells Through Activation of Erk1/2 MAP Kinase
- (2011) Manuela Zonca et al. TISSUE ENGINEERING PART A
- Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus
- (2010) Kai W. Bekar et al. ARTHRITIS AND RHEUMATISM
- Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses
- (2010) Claudia Bossen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients
- (2010) LD Zhao et al. LUPUS
- B-cell Activating Factor of the Tumour Necrosis Factor Family Expression in Blood Monocytes and T Cells from Patients with Primary Sjögren’s Syndrome
- (2010) F. Lavie et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus
- (2009) Van Trung Chu et al. ARTHRITIS AND RHEUMATISM
- BAFF-R promotes cell proliferation and survival through interaction with IKKβ and NF-κB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells
- (2009) Lingchen Fu et al. BLOOD
- Adipocytes as Immune Cells: Differential Expression of TWEAK, BAFF, and APRIL and Their Receptors (Fn14, BAFF-R, TACI, and BCMA) at Different Stages of Normal and Pathological Adipose Tissue Development
- (2009) V.-I. Alexaki et al. JOURNAL OF IMMUNOLOGY
- Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia
- (2009) Kwang Soo Kim et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Molecular cloning, in vitro expression and bioactivity of quail BAFF
- (2009) Chuan-mei Chen et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort
- (2009) Jacques-Eric Gottenberg et al. ARTHRITIS RESEARCH & THERAPY
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- (2008) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Effect of interleukin-2 on synthesis of B cell activating factor belonging to the tumor necrosis factor family (BAFF) in human peripheral blood mononuclear cells
- (2008) Katsuya Suzuki et al. CYTOKINE
- Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways
- (2008) Marc Ittah et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signaling
- (2008) Jason E Stadanlick et al. NATURE IMMUNOLOGY
- Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms
- (2008) Annie George-Chandy et al. ARTHRITIS RESEARCH & THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started